• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Transdermal Hormone Replacement. Products, Players, Markets, Forecasts - Product Image

Transdermal Hormone Replacement. Products, Players, Markets, Forecasts

  • Published: June 2012
  • Region: Global
  • Greystone Associates

As life expectancy in the developed world increases and populations age, the incidence and associated morbidity of decreasing hormone levels have come to the forefront as a quality-of-life issue for patients and their families. For the past two decades, the healthcare industry has responded to this clinical need by developing, testing and marketing hormone replacement therapy (HRT) products. Because of their ease-of-use and dosing characteristics, drug developers are continuing to turn to transdermal delivery systems for HRT products. There are more than 40 million post-menopausal women in the United States alone, and this group is expected to grow by 50% by 2020. With the aging of the population worldwide, conditions and diseases such as menopause, osteoporosis and heart disease, which may benefit from hormone replacement therapy, are expected to become significantly more prevalent. The industry continues to attract interest in the form of new participants and products. While the global market continues to be dominated by the FDA-approved HRT products of major pharmaceutical firms, regional markets are a bit more competitive, and present unique challenges to transdermal HRT sector READ MORE >

Executive Summary

Scope and Definitions
The Hormone Replacement Therapy Market
The Opportunity for Transdermal Hormone Replacement Therapy

The Hormone Replacement Therapy Market Opportunity

Evolution in HRT Guidelines
Regional Factors in HRT Practice
Hormone Replacement Therapy Demand Drivers
Competitive Landscape
Factors Limiting Growth

Transdermal Drug Delivery Dynamics

Transdermal HRT Patches
Patch Designs and Construction
Transdermal Patch Manufacturing and Packaging
The Patch Manufacturing Ecosystem
Patch Economics
Transdermal HRT Gels
Transdermal Formulations
IP and Proprietary Technology
Limitations of Topical Gels & Emulsions
Transdermal HRT Sprays

Transdermal HRT Indications and Markets

Hypoestrogenism
Hypogonadism
Menopause
Vasomotor Symptoms
Vaginal Atrophy
Postmenopausal Osteoporosis

Transdermal HRT Product Assessments and Market Prospects

Approved Transdermal HRT Products
Estradiol
Ascend
Azur
Bayer Healthcare
Graceway
KV Pharm
Mylan
Novartis
Watson Laboratories
Upsher-Smith
Faran SA
Janssen-Cilag
Meda
Shiseido
Solvay
Estradiol Levonorgestrel
Bayer Healthcare
Estradiol/Norethindrone
Novartis
Testosterone
Abbott Labs
Auxilium
Endo Pharms
Teva
Watson Laboratories
Development-Stage Transdermal HRT Products
Estrogen
Testosterone
Other Hormones

Transdermal Hormone Replacement Market Factors

Regional Regulations
Clinical Trials
Quality and Reliability
Indications Prescribing Guidelines and Off-Label Prescribing
Managed Care and Payor Initiatives
Rx-to-OTC Switching

Market Forecasts

Forecast Methodology
Forecasts by Region
Forecasts by Drug Class
Forecasts by Delivery Form Factor
Market Share Data

Market Participant Profiles

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos